Trial intelligence / Profile preview

miRNAs in Clopidogrel Low Response

NCT02447809Phase 4Unknown

Sponsor
Jiangsu Provincial People's Hospital
Start
Jan 2015
Primary completion
Dec 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of clopidogrel in coronary artery disease (CAD), sponsored by Jiangsu Provincial People's Hospital. Status: unknown.

02

Drugs

clopidogrel
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT02447809.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02447809.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call